Global Haemophilia Drug Market Growth (Status and Outlook) 2022-2028
- LP 4906640
- 101 Pages
- March 2022
- Pharmaceuticals
The United States Haemophilia Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Haemophilia Drug market, reaching US$ million by the year 2028. As for the Europe Haemophilia Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Haemophilia Drug players cover Bayer, Novo Nordisk, Pfizer, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Haemophilia Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Coagulation Factor Therapy Drugs
Non-coagulation Factor Therapy Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Medical Institutions
Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
Novo Nordisk
Pfizer
Roche
Baxter
Sinopharm
Shanghai Raas Blood Products
China Biologic Products
Hualan Bio
CGE Healthcare
Sinocelltech Group
Shanxi Kangbao Biological
CTTQ
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Haemophilia Drug Market Size 2017-2028
2.1.2 Haemophilia Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Haemophilia Drug Segment by Type
2.2.1 Coagulation Factor Therapy Drugs
2.2.2 Non-coagulation Factor Therapy Drugs
2.3 Haemophilia Drug Market Size by Type
2.3.1 Haemophilia Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Haemophilia Drug Market Size Market Share by Type (2017-2022)
2.4 Haemophilia Drug Segment by Application
2.4.1 Medical Institutions
2.4.2 Pharmacies
2.5 Haemophilia Drug Market Size by Application
2.5.1 Haemophilia Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Haemophilia Drug Market Size Market Share by Application (2017-2022)
3 Haemophilia Drug Market Size by Player
3.1 Haemophilia Drug Market Size Market Share by Players
3.1.1 Global Haemophilia Drug Revenue by Players (2020-2022)
3.1.2 Global Haemophilia Drug Revenue Market Share by Players (2020-2022)
3.2 Global Haemophilia Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Haemophilia Drug by Regions
4.1 Haemophilia Drug Market Size by Regions (2017-2022)
4.2 Americas Haemophilia Drug Market Size Growth (2017-2022)
4.3 APAC Haemophilia Drug Market Size Growth (2017-2022)
4.4 Europe Haemophilia Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Haemophilia Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Haemophilia Drug Market Size by Country (2017-2022)
5.2 Americas Haemophilia Drug Market Size by Type (2017-2022)
5.3 Americas Haemophilia Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Haemophilia Drug Market Size by Region (2017-2022)
6.2 APAC Haemophilia Drug Market Size by Type (2017-2022)
6.3 APAC Haemophilia Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Haemophilia Drug by Country (2017-2022)
7.2 Europe Haemophilia Drug Market Size by Type (2017-2022)
7.3 Europe Haemophilia Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Haemophilia Drug by Region (2017-2022)
8.2 Middle East & Africa Haemophilia Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Haemophilia Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Haemophilia Drug Market Forecast
10.1 Global Haemophilia Drug Forecast by Regions (2023-2028)
10.1.1 Global Haemophilia Drug Forecast by Regions (2023-2028)
10.1.2 Americas Haemophilia Drug Forecast
10.1.3 APAC Haemophilia Drug Forecast
10.1.4 Europe Haemophilia Drug Forecast
10.1.5 Middle East & Africa Haemophilia Drug Forecast
10.2 Americas Haemophilia Drug Forecast by Country (2023-2028)
10.2.1 United States Haemophilia Drug Market Forecast
10.2.2 Canada Haemophilia Drug Market Forecast
10.2.3 Mexico Haemophilia Drug Market Forecast
10.2.4 Brazil Haemophilia Drug Market Forecast
10.3 APAC Haemophilia Drug Forecast by Region (2023-2028)
10.3.1 China Haemophilia Drug Market Forecast
10.3.2 Japan Haemophilia Drug Market Forecast
10.3.3 Korea Haemophilia Drug Market Forecast
10.3.4 Southeast Asia Haemophilia Drug Market Forecast
10.3.5 India Haemophilia Drug Market Forecast
10.3.6 Australia Haemophilia Drug Market Forecast
10.4 Europe Haemophilia Drug Forecast by Country (2023-2028)
10.4.1 Germany Haemophilia Drug Market Forecast
10.4.2 France Haemophilia Drug Market Forecast
10.4.3 UK Haemophilia Drug Market Forecast
10.4.4 Italy Haemophilia Drug Market Forecast
10.4.5 Russia Haemophilia Drug Market Forecast
10.5 Middle East & Africa Haemophilia Drug Forecast by Region (2023-2028)
10.5.1 Egypt Haemophilia Drug Market Forecast
10.5.2 South Africa Haemophilia Drug Market Forecast
10.5.3 Israel Haemophilia Drug Market Forecast
10.5.4 Turkey Haemophilia Drug Market Forecast
10.5.5 GCC Countries Haemophilia Drug Market Forecast
10.6 Global Haemophilia Drug Forecast by Type (2023-2028)
10.7 Global Haemophilia Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Haemophilia Drug Product Offered
11.1.3 Bayer Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Haemophilia Drug Product Offered
11.2.3 Novo Nordisk Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Haemophilia Drug Product Offered
11.3.3 Pfizer Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Haemophilia Drug Product Offered
11.4.3 Roche Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Baxter
11.5.1 Baxter Company Information
11.5.2 Baxter Haemophilia Drug Product Offered
11.5.3 Baxter Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Baxter Main Business Overview
11.5.5 Baxter Latest Developments
11.6 Sinopharm
11.6.1 Sinopharm Company Information
11.6.2 Sinopharm Haemophilia Drug Product Offered
11.6.3 Sinopharm Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sinopharm Main Business Overview
11.6.5 Sinopharm Latest Developments
11.7 Shanghai Raas Blood Products
11.7.1 Shanghai Raas Blood Products Company Information
11.7.2 Shanghai Raas Blood Products Haemophilia Drug Product Offered
11.7.3 Shanghai Raas Blood Products Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Shanghai Raas Blood Products Main Business Overview
11.7.5 Shanghai Raas Blood Products Latest Developments
11.8 China Biologic Products
11.8.1 China Biologic Products Company Information
11.8.2 China Biologic Products Haemophilia Drug Product Offered
11.8.3 China Biologic Products Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 China Biologic Products Main Business Overview
11.8.5 China Biologic Products Latest Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Company Information
11.9.2 Hualan Bio Haemophilia Drug Product Offered
11.9.3 Hualan Bio Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hualan Bio Main Business Overview
11.9.5 Hualan Bio Latest Developments
11.10 CGE Healthcare
11.10.1 CGE Healthcare Company Information
11.10.2 CGE Healthcare Haemophilia Drug Product Offered
11.10.3 CGE Healthcare Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CGE Healthcare Main Business Overview
11.10.5 CGE Healthcare Latest Developments
11.11 Sinocelltech Group
11.11.1 Sinocelltech Group Company Information
11.11.2 Sinocelltech Group Haemophilia Drug Product Offered
11.11.3 Sinocelltech Group Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sinocelltech Group Main Business Overview
11.11.5 Sinocelltech Group Latest Developments
11.12 Shanxi Kangbao Biological
11.12.1 Shanxi Kangbao Biological Company Information
11.12.2 Shanxi Kangbao Biological Haemophilia Drug Product Offered
11.12.3 Shanxi Kangbao Biological Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Shanxi Kangbao Biological Main Business Overview
11.12.5 Shanxi Kangbao Biological Latest Developments
11.13 CTTQ
11.13.1 CTTQ Company Information
11.13.2 CTTQ Haemophilia Drug Product Offered
11.13.3 CTTQ Haemophilia Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 CTTQ Main Business Overview
11.13.5 CTTQ Latest Developments
12 Research Findings and Conclusion
Table 1. Haemophilia Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Coagulation Factor Therapy Drugs
Table 3. Major Players of Non-coagulation Factor Therapy Drugs
Table 4. Haemophilia Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Haemophilia Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Haemophilia Drug Market Size Market Share by Type (2017-2022)
Table 7. Haemophilia Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Haemophilia Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Haemophilia Drug Market Size Market Share by Application (2017-2022)
Table 10. Global Haemophilia Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Haemophilia Drug Revenue Market Share by Player (2020-2022)
Table 12. Haemophilia Drug Key Players Head office and Products Offered
Table 13. Haemophilia Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Haemophilia Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Haemophilia Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas Haemophilia Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Haemophilia Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas Haemophilia Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Haemophilia Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas Haemophilia Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Haemophilia Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC Haemophilia Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Haemophilia Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC Haemophilia Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Haemophilia Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC Haemophilia Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Haemophilia Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe Haemophilia Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Haemophilia Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe Haemophilia Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Haemophilia Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe Haemophilia Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Haemophilia Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Haemophilia Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Haemophilia Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Haemophilia Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Haemophilia Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Haemophilia Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Haemophilia Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Haemophilia Drug
Table 43. Key Market Challenges & Risks of Haemophilia Drug
Table 44. Key Industry Trends of Haemophilia Drug
Table 45. Global Haemophilia Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Haemophilia Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Haemophilia Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Haemophilia Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Haemophilia Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Haemophilia Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bayer Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 52. Bayer Haemophilia Drug Product Offered
Table 53. Bayer Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Novo Nordisk Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 57. Novo Nordisk Haemophilia Drug Product Offered
Table 58. Novo Nordisk Main Business
Table 59. Novo Nordisk Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novo Nordisk Latest Developments
Table 61. Pfizer Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 62. Pfizer Haemophilia Drug Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Roche Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 67. Roche Haemophilia Drug Product Offered
Table 68. Roche Main Business
Table 69. Roche Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Roche Latest Developments
Table 71. Baxter Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 72. Baxter Haemophilia Drug Product Offered
Table 73. Baxter Main Business
Table 74. Baxter Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Baxter Latest Developments
Table 76. Sinopharm Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 77. Sinopharm Haemophilia Drug Product Offered
Table 78. Sinopharm Main Business
Table 79. Sinopharm Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sinopharm Latest Developments
Table 81. Shanghai Raas Blood Products Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 82. Shanghai Raas Blood Products Haemophilia Drug Product Offered
Table 83. Shanghai Raas Blood Products Main Business
Table 84. Shanghai Raas Blood Products Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Shanghai Raas Blood Products Latest Developments
Table 86. China Biologic Products Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 87. China Biologic Products Haemophilia Drug Product Offered
Table 88. China Biologic Products Main Business
Table 89. China Biologic Products Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. China Biologic Products Latest Developments
Table 91. Hualan Bio Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 92. Hualan Bio Haemophilia Drug Product Offered
Table 93. Hualan Bio Main Business
Table 94. Hualan Bio Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Hualan Bio Latest Developments
Table 96. CGE Healthcare Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 97. CGE Healthcare Haemophilia Drug Product Offered
Table 98. CGE Healthcare Main Business
Table 99. CGE Healthcare Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. CGE Healthcare Latest Developments
Table 101. Sinocelltech Group Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 102. Sinocelltech Group Haemophilia Drug Product Offered
Table 103. Sinocelltech Group Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Sinocelltech Group Main Business
Table 105. Sinocelltech Group Latest Developments
Table 106. Shanxi Kangbao Biological Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 107. Shanxi Kangbao Biological Haemophilia Drug Product Offered
Table 108. Shanxi Kangbao Biological Main Business
Table 109. Shanxi Kangbao Biological Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Shanxi Kangbao Biological Latest Developments
Table 111. CTTQ Details, Company Type, Haemophilia Drug Area Served and Its Competitors
Table 112. CTTQ Haemophilia Drug Product Offered
Table 113. CTTQ Main Business
Table 114. CTTQ Haemophilia Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. CTTQ Latest Developments
List of Figures
Figure 1. Haemophilia Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Haemophilia Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Haemophilia Drug Market Size Market Share by Type in 2021
Figure 7. Haemophilia Drug in Medical Institutions
Figure 8. Global Haemophilia Drug Market: Medical Institutions (2017-2022) & ($ Millions)
Figure 9. Haemophilia Drug in Pharmacies
Figure 10. Global Haemophilia Drug Market: Pharmacies (2017-2022) & ($ Millions)
Figure 11. Global Haemophilia Drug Market Size Market Share by Application in 2021
Figure 12. Global Haemophilia Drug Revenue Market Share by Player in 2021
Figure 13. Global Haemophilia Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Haemophilia Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC Haemophilia Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe Haemophilia Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Haemophilia Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas Haemophilia Drug Value Market Share by Country in 2021
Figure 19. Americas Haemophilia Drug Consumption Market Share by Type in 2021
Figure 20. Americas Haemophilia Drug Market Size Market Share by Application in 2021
Figure 21. United States Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Haemophilia Drug Market Size Market Share by Region in 2021
Figure 26. APAC Haemophilia Drug Market Size Market Share by Application in 2021
Figure 27. China Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Haemophilia Drug Market Size Market Share by Country in 2021
Figure 34. Europe Haemophilia Drug Market Size Market Share by Type in 2021
Figure 35. Europe Haemophilia Drug Market Size Market Share by Application in 2021
Figure 36. Germany Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Haemophilia Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Haemophilia Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Haemophilia Drug Market Size Market Share by Application in 2021
Figure 44. Egypt Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Haemophilia Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 57. China Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 61. India Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 64. France Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Haemophilia Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Haemophilia Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
